tiprankstipranks
Advertisement
Advertisement

PROK Stock Latest News

ProKidney appoints Greg Madison as chief commercial officer
The FlyProKidney appoints Greg Madison as chief commercial officer
18d ago
PROK
Trade Policy Risks: How Evolving U.S. Tariffs and Export Rules Threaten ProKidney Corp.’s Supply Chain and Financial Stability
PremiumCompany Announcements
Trade Policy Risks: How Evolving U.S. Tariffs and Export Rules Threaten ProKidney Corp.’s Supply Chain and Financial Stability
24d ago
PROK
ProKidney: Extended Development Timeline and Deferred Catalysts Support Balanced Hold Rating
PremiumRatings
ProKidney: Extended Development Timeline and Deferred Catalysts Support Balanced Hold Rating
25d ago
PROK
ProKidney reports Q4 EPS (52c), consensus (15c)
PremiumThe Fly
ProKidney reports Q4 EPS (52c), consensus (15c)
25d ago
PROK
Optimized PROACT 1 Design, Preserved Statistical Power, and Clear Regulatory Path Support Buy Rating on ProKidney
PremiumRatings
Optimized PROACT 1 Design, Preserved Statistical Power, and Clear Regulatory Path Support Buy Rating on ProKidney
2M ago
PROK
ProKidney: Preserved Long-Term Opportunity but Heightened Timeline Risk Supports Continued Hold Rating
PremiumRatingsProKidney: Preserved Long-Term Opportunity but Heightened Timeline Risk Supports Continued Hold Rating
2M ago
PROK
ProKidney Expands Phase 3 REGEN-006 Trial Enrollment Plans
Premium
Company Announcements
ProKidney Expands Phase 3 REGEN-006 Trial Enrollment Plans
2M ago
8K
PROK
Advancing Rilparencel in Diabetic CKD: De-Risked PROACT 1 Trial Design and Strong Enrollment Support Buy Rating on ProKidney
Premium
Ratings
Advancing Rilparencel in Diabetic CKD: De-Risked PROACT 1 Trial Design and Strong Enrollment Support Buy Rating on ProKidney
3M ago
PROK
ProKidney Advances Rilparencel Program and Manufacturing Expansion
PremiumCompany Announcements
ProKidney Advances Rilparencel Program and Manufacturing Expansion
3M ago
8K
PROK
ProKidney initiated with a Buy at H.C. Wainwright
PremiumThe Fly
ProKidney initiated with a Buy at H.C. Wainwright
4M ago
PROK
PROK Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
PROK Upcoming Earnings Report: What to Expect?
5M ago
PROK
ProKidney reports Q3 EPS (12c), consensus (14c)
PremiumThe Fly
ProKidney reports Q3 EPS (12c), consensus (14c)
5M ago
PROK
ProKidney presents results from Phase 2 REGEN-007 trial of rilparencel
PremiumThe FlyProKidney presents results from Phase 2 REGEN-007 trial of rilparencel
5M ago
PROK
Prokidney’s REACT Study: A Potential Game Changer for Kidney Disease Treatment
Premium
Company Announcements
Prokidney’s REACT Study: A Potential Game Changer for Kidney Disease Treatment
6M ago
PROK
Prokidney’s Long-Term Study on REACT Therapy: A Potential Game-Changer for CKD
Premium
Company Announcements
Prokidney’s Long-Term Study on REACT Therapy: A Potential Game-Changer for CKD
6M ago
PROK
Prokidney’s Long-Term Study on Renal Therapy: A Potential Game Changer for CKD
PremiumCompany Announcements
Prokidney’s Long-Term Study on Renal Therapy: A Potential Game Changer for CKD
6M ago
PROK
ProKidney Sells Greensboro Property for $19.1 Million
PremiumCompany Announcements
ProKidney Sells Greensboro Property for $19.1 Million
6M ago
8K
PROK
ProKidney: Hold Rating Amid Encouraging Developments and Cautious Outlook
PremiumRatings
ProKidney: Hold Rating Amid Encouraging Developments and Cautious Outlook
8M ago
PROK
ProKidney Corp. Reports Q2 2025 Financial Results
PremiumCompany Announcements
ProKidney Corp. Reports Q2 2025 Financial Results
8M ago
PROK
ProKidney reports Q2 EPS (13c), consensus (14c)
PremiumThe FlyProKidney reports Q2 EPS (13c), consensus (14c)
8M ago
PROK
Prokidney Corp options imply 15.7% move in share price post-earnings
Premium
The Fly
Prokidney Corp options imply 15.7% move in share price post-earnings
8M ago
PROK
Prokidney Corp options imply 13.0% move in share price post-earnings
Premium
The Fly
Prokidney Corp options imply 13.0% move in share price post-earnings
8M ago
PROK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >